Frequently Asked
Questions

1. What is Lina Manufacturing?

At Lina, we cultivate a culture where every team member is valued, supported and connected. While we are committed to excellence in pharmaceutical production, we also prioritize personal growth, well-being and collaboration. With a vibrant calendar of events, team activities and initiatives that celebrate diversity, Life at Lina is about thriving together making meaningful contributions to healthcare while enjoying a workplace full of energy, support and shared success.

All products are manufactured at Lina’s facility in Kadawatha, Sri Lanka — the country’s only GMP-certified MDI manufacturing plant.

Lina manufactures six key product categories: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Dry Powder Capsules, Nasal Sprays, Tablets, and Devices (such as the Ventohaler). These span both respiratory care and pain management therapy areas.

Lina holds WHO Good Manufacturing Practices (GMP) certification and is NMRA-approved. Our manufacturing processes meet global pharmaceutical standards, with a 99.5% purity rate, 97% dose consistency, over 45 quality control checks per batch, and a 0% defect rate target.

Lina products are available through government healthcare institutions and private pharmacies across Sri Lanka. If you are a healthcare distributor or institution, you may contact us directly to discuss supply arrangements.

Through our SUSTAINABILITY initiatives, Lina fosters community engagement, prioritizes employee well-being, and works toward a healthier and more sustainable future for Sri Lanka.

Visit the Careers page on our website to explore current opportunities. We welcome talented individuals who are passionate about healthcare and innovation to join our team.

Lina fosters an innovative and community-oriented workplace culture. We believe in empowering our people to drive meaningful change in respiratory healthcare, offering a dynamic environment where ideas and skills make a real impact.

Yes. Lina is backed by strong R&D capabilities and continuously invests in product innovation to address evolving healthcare needs in Sri Lanka and beyond. This includes patented technologies in dry powder inhaler formulations.